The AF Centre of Excellence is dedicated to furthering knowledge and treatments of AF and education about AF. The Centre is involved in active research with regular presentation of clinical abstracts at the Cardiac Society of Australia and New Zealand's (CSANZ) annual scientific meeting and continued publication in peer- reviewed medical journals. The Centre participates in several international clinical trials on leading edge AF treatments.
Contact us for more information on Clinical Trials
Coherex WaveCrest® The purpose of this study is a "first in man" assessment of the WaveCrest device which is designed to be placed in the opening of the left atrial appendage (LAA) to prevent stroke in patients with atrial fibrillation.
Status: enrollment closed.
ZERO-AF "Clinical Evaluation of the Blazer Open-Irrigated Ablation Catheter for the Treatment of Paroxysmal Atrial Fibrillation"
The purpose of this study is to establish the safety and effectiveness of the Blazer Open-Irrigated radiofrequency ablation catheter for the treatment of drug refractory, recurrent, symptomatic, paroxysmal atrial fibrillation.
Status: currently enrolling.